VYEPTI

Google image searchProduct monograph

Active ingredient

eptinezumab, 300 MG/3 ML

DIN: 02542269

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE-USE VIAL

Schedule: Prescription / Schedule D

Company: LUNDBECK CANADA INC

Date: 01-JUL-2024

ATC:

• N02 — ANALGESICS (ATC, ATC/DDD, )
• N02C — ANTIMIGRAINE PREPARATIONS (ATC, ATC/DDD)
• N02CD — Calcitonin gene-related peptide (CGRP) antagonists (ATC, ATC/DDD)
• N02CD05 — EPTINEZUMAB (ATC/DDD)

External Links for Vyepti

Search on Google

• Vyepti side effects
• Vyepti dosage
• eptinezumab side effects
• eptinezumab dosage

Lundbeck Canada Inc

Go to Lundbeck website to see drug product details. Sometimes you can find vyepti photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.